<DOC>
	<DOCNO>NCT00984789</DOCNO>
	<brief_summary>400 healthy woman need contraception ask participate study . Half give EVRA , half give FC Patch low . They expect apply patch 21 day cycle , 7 cycle total . The study compare pattern menstrual bleed two treatment , plus effective preventing pregnancy , general safety , acceptability participant .</brief_summary>
	<brief_title>Birth Control Patch Study</brief_title>
	<detailed_description />
	<mesh_term>Norelgestromin</mesh_term>
	<mesh_term>Femovan</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Healthy woman request contraception age 1835 year old Smokers must older 30 time informed consent History regular cyclic menstrual period , normal cervical smear Pregnancy lactation Obesity ( BMI &gt; 30 ) , hypersensitivity ingredient study drug , significant skin reaction transdermal preparation , diseases/conditions compromise function body system ( result alter absorption/accumulation/ metabolism/excretion study drug ) , diseases / condition may worsen hormonal treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Transdermal Patch</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Pregnancy</keyword>
</DOC>